Generic Biologics: European-Style Regulation Is The Answer, Big Pharma Says

The Senate Health Committee hearing on developing an approval pathway for generic biologics put the brand-name pharmaceutical industry in the unusual position of advocating that Congress adopt a European-style Rx oversight system